Navigation Links
Lilly Contributes $11.1 Million to United Way Annual Campaign
Date:11/13/2008

Lilly's gift makes up nearly 23% of fund raising goal for Central Indiana

INDIANAPOLIS, Nov. 13 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) President and Chief Executive Officer John Lechleiter today presented an $11.1 million check to the United Way of Central Indiana for its and other United Way chapters' 2008 fundraising campaigns. The check represents the contributions of Lilly employees and retirees across the United States with a matching gift amount from the Lilly Foundation. Lilly's commitment represents nearly 23 percent of the United Way of Central Indiana's 2008 annual campaign goal.

"In the face of difficult and unprecedented economic conditions confronting all of us, Lilly exceeded its United Way fundraising goal by $100,000," said Lechleiter. "We're very proud of the dollar commitment we're making today. We're even more proud of the thousands of Lilly employees who support United Way agencies and services in their local communities through donations of their time and talents, as well as their financial resources."

In 2008, more than 450 Lilly employees served as tutors for United Way's ReadUP program, and more than 9,000 employees participated in the company's first-ever Global Day of Service, including 278 employees who supported projects benefiting United Way. Additionally, Lilly employees donated:

-- More than 21,000 school supplies to BackPack Attack

-- More than 1,600 bags of clothing to Goodwill Industries

-- More than 300 books

-- 500 blankets to the American Red Cross.

"Lilly's unwavering commitment to United Way of Central Indiana speaks to the dedication and passion of its employees," said Ellen Annala, president and chief executive officer of the United Way. "We're proud to have Lilly as one of our partners, and appreciate their contributions and employee support for improving our community. They are a great example of what we mean when we say 'Live United'."

Lilly is one of 125 National Corporate Leadership (NCL) companies that with their employees are leading the charge in communities across the country through their commitment to giving, advocating and volunteering.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com. C-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- Roka Bioscience, Inc. (NASDAQ: ROKA ), a molecular ... of foodborne pathogens today announced the appointment of Mary Duseau ... , the Company,s President and CEO since 2009, who will assume ... changes are effective today. In addition, Ms. Duseau will ... ...
(Date:1/17/2017)... , Jan. 17, 2017   Pulmatrix, Inc . ... company developing innovative inhaled therapies to address serious pulmonary ... fungal infections in the lungs of CF patients, PUR1900, ... (QIDP) by the U.S. Food & Drug Administration. ... designed to speed the development of novel drugs against ...
(Date:1/17/2017)... , Jan. 17, 2017 Research ... report "Molecular Diagnostics - Technologies, Markets and Companies" ... ... diagnostics has increased remarkably during the past few years. More ... developing molecular diagnostics and 342 of these are profiled in ...
(Date:1/17/2017)...  Northwell Health today announced a collaboration with ... research. As New ... Northwell Health diagnoses and treats 19,000 new cancer ... Germany -based oncology research company working ... greatly expand cancer biobanking activities within Northwell Health ...
Breaking Biology Technology:
(Date:12/8/2016)... Calif. , Dec. 8, 2016  Singulex, Inc., ... Molecule Counting technology, entered into a license and supply ... serving science. The agreement provides Singulex access to Thermo ... Europe is used to diagnose systemic ... United States to aid in assessing the ...
(Date:12/7/2016)... , December 7, 2016 BioCatch , ... expansion of its patent portfolio, which grew to over 40 granted and ... , , ... recently filed patent entitled " System, Device, and Method Estimating ... that enables device makers to forego costly hardware components needed to estimate ...
(Date:12/7/2016)... 7, 2016   Veridium , a leader ... of new CEO James Stickland . Stickland, ... of experience, has served in senior executive roles ... specialized in expanding a pipeline of venture capital ... most recently served as managing director of U.K.-based ...
Breaking Biology News(10 mins):